Compare DigitalOcean Holdings Inc (DOCN) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigitalOcean Holdings Inc vs Johnson & Johnson — how do they compare? DigitalOcean Holdings Inc trades at $134.82 (market cap $14.57B), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 42.4× DigitalOcean Holdings Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while DigitalOcean Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold DigitalOcean Holdings Inc for 43 Days and Johnson & Johnson for 129 Days on average.
| DOCN | JNJ | |
|---|---|---|
Market Cap | $14.57B | $618.09B |
Volume | 2,261,786 | 6,050,983 |
Sector | Technology | Health |
52-Week High | $181.29 | $278.43 |
52-Week Low | $37.30 | $186.00 |
Typical Hold Time | 43 Days | 129 Days |
Enterprise Value | $15.33B | $646.37B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DigitalOcean (DOCN) trades at $123.9, down 2.66% over 24 hours, with a bullish technical signal driven by oversold RSI levels near support at $120. The company demonstrates strong fundamental momentum, with Q2 2026 EPS of $0.45 beating expectations and revenue growth accelerating to 29% year-over-year. Recent news highlights expansion into AI-native cloud services, including Agent Droplets and a $725 million equipment financing facility secured in September 2026 to fund capacity growth.
Outlook remains positive given analyst consensus favoring Buy ratings and a $172.73 price target, though risks include high valuation multiples and negative shareholder equity. Earnings growth and AI-driven demand present upside, while execution risks and competitive pressures in cloud services warrant monitoring.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).
JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
